Tag Archives: HIV

EU regulator backs Gilead’s twice-yearly injection for HIV prevention  Reuters E.U. regulator approves injectable HIV drug that experts say could help stop transmission  NBC News EU regulators back twice-yearly HIV injection  Euronews.com Yeztugo approval: A new era in HIV prevention  Newsday Expert: Lenacapavir Shows 100% Efficacy in Key Trial, Offering Transformative Twice-Yearly HIV Prevention  Pharmacy Times Source link

LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is “highly effective” and “considered to be of major …

EU regulators back twice-yearly HIV injection  Euronews.com EU regulator backs Gilead’s twice-yearly injection for HIV prevention  Reuters EU regulator approves injectable HIV drug that experts say could help stop transmission  PBS Yeztugo approval: A new era in HIV prevention  Newsday Does six-monthly PrEP have a future following the collapse of global HIV funding?  Aidsmap Source link

How a ‘cluster’ of HIV cases in Penobscot County became one of Maine’s largest outbreaks  The Portland Press HeraldView Full Coverage on Google News Source link

Georgia tops U.S. in HIV rate, remains in top 5 for other major STDs  11Alive.com STDs nationwide on the rise. Where does Utah stand?  Deseret News Where does Delaware rank in nationwide STD report?  The News Journal Georgia ranks among worst states for STDs  95.5 WSB New study ranks U.S. states with highest STI rates  Advocate.com Source link

The World Health Organization is now recommending that countries include a newly approved HIV drug for prevention, lenacapavir, as a tool in their efforts to fight HIV infections, especially for groups most at risk and in areas where the burden of HIV remains high.This landmark guidance, released at the 13th International AIDS Society Conference in Kigali on July 14 – …

An image depicting the optogenetic screening process (Image source: AI-generated image) In a major breakthrough, researchers have identified a new class of broad-spectrum antiviral compounds that work by amplifying a cell’s own natural defenses, showing effectiveness against viruses like Zika, herpes, and RSV. A team of researchers just discovered compounds that could lead to a new generation of antiviral drugs …

WHO recommends Gilead’s twice-yearly injection for HIV prevention  Reuters WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight  CNN Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis  World Health Organization (WHO) Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost  STAT WHO urges rollout of first …

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response. The guidelines are being issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, …

Facebook Tweet Email Link The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for groups most at risk and in areas where the burden of HIV remains high. The global recommendation – issued Monday at the International AIDS Conference …